arrow
Z

Zhang, Jianjun

university of texas system
H指数:0
被引数:16

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
2024-01-265
OAAI
INTEGRATIVE IMMUNOMICS HIGHLIGHT THE IMMUNOMODULATORY IMPACT OF NEOADJUVANT CHEMOTHERAPY AND IMMUNE-BASED TREATMENTS IN RESECTED NON-SMALL-CELL LUNG CANCER
2021-11-100
OA
COMBINED IL-2, AGONISTIC CD3 AND 4-1BB STIMULATION PRESERVE CLONOTYPE HIERARCHY IN PROPAGATED NON-SMALL CELL LUNG CANCER TUMOR-INFILTRATING LYMPHOCYTES
2021-11-100
OA
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
2021-08-10170
OAAI
COMBINED NEOADJUVANT CHEMO-IMMUNOTHERAPY THERAPY ACHIEVES SUPERIOR DOWNSTAGING OF RESECTABLE NON-SMALL CELL LUNG CANCER AS COMPARED TO CHEMOTHERAPY, MONO OR DUAL IMMUNOTHERAPY
2020-11-093
PREAI
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
2020-07-1523
OAAI
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
2020-06-1534
OAAI
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
2020-04-2839
OAAI
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
2020-02-1475
OAAI
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC

奥希替尼的EGFR依赖性和非依赖性耐药机制以及EGFR突变型NSCLC进展后继续治疗的前景

2018-12-13306
OAAI
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
2016-12-15127
OA